EGFR mutant status and tyrosine-kinase inhibitors affect the GKRS outcomes for NSCLC brain metastases.
J Neurooncol
; 159(3): 675-684, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-35976545
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Radiosurgery
/
Carcinoma, Non-Small-Cell Lung
/
Protein Kinase Inhibitors
/
ErbB Receptors
/
Lung Neoplasms
Type of study:
Observational_studies
Limits:
Humans
Language:
En
Journal:
J Neurooncol
Year:
2022
Type:
Article
Affiliation country:
Taiwan